Lifecore Biomedical (LFCR)
NASDAQ:LFCR
Holding LFCR?
Track your performance easily

Lifecore Biomedical (LFCR) Financial Statements

107 Followers

Lifecore Biomedical Financial Overview

Lifecore Biomedical's market cap is currently ―. The company's EPS TTM is $0.231; its P/E ratio is 22.42; Lifecore Biomedical is scheduled to report earnings on October 2, 2024, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
May 24Feb 24Nov 23Aug 23May 23
Income Statement-
Total Revenue$ 37.88M$ 35.70M$ 30.15M$ 24.52M$ 25.52M
Gross Profit$ 17.27M$ 11.89M$ 9.96M$ 2.73M$ 8.41M
EBIT$ -19.07M$ 19.29M$ 18.25M$ -8.58M$ -25.36M
EBITDA$ -16.82M$ 21.52M$ 20.46M$ -6.42M$ -22.47M
Net Income Common Stockholders$ -4.00M$ 15.63M$ 14.22M$ -10.01M$ -35.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.46M$ 3.07M$ 3.22M$ 8.64M$ 19.09M
Total Assets$ 253.96M$ 246.24M$ 245.82M$ 245.62M$ 253.54M
Total Debt$ 121.28M$ 117.02M$ 109.74M$ 107.92M$ 101.64M
Net Debt$ 112.82M$ 113.95M$ 106.52M$ 99.28M$ 82.55M
Total Liabilities$ 200.06M$ 186.81M$ 203.47M$ 219.07M$ 218.46M
Stockholders Equity$ 11.31M$ 17.69M$ 1.42M$ -13.56M$ -4.23M
Cash Flow-
Free Cash Flow$ 8.64M$ -7.79M$ -2.97M$ -13.38M$ 12.05M
Operating Cash Flow$ 8.64M$ -1.53M$ 1.01M$ -8.33M$ -272.00K
Investing Cash Flow$ -2.64M$ -6.25M$ -3.98M$ -5.05M$ -8.16M
Financing Cash Flow$ -614.00K$ 7.64M$ -2.45M$ 2.93M$ 24.57M
Currency in USD

Lifecore Biomedical Earnings and Revenue History

Lifecore Biomedical Debt to Assets

Lifecore Biomedical Cash Flow

Lifecore Biomedical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis